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Transcription activator-like effector nucleases (TALENs) are novel engineered DNA nucleases, and have been proven
to be effective for gene specific targeting in various species. Recently we reported gene disruptions in Xenopus
embryos by using TALENs. Here we summarize the protocol that is used in our studies for gene disruption. This
protocol covers selection of TALEN targeting sites, TALEN assembly with a modified Golden Gate method, and
injection of TALEN mRNAs into Xenopus tropicalis embryos. We also provide details for detection of somatic and
germ line transmitted mutations. And finally, we briefly describe establishment of knockout Xenopus lines. This
protocol will facilitate broader applications of TALENs in studies of Xenopus biology.Introduction
Xenopus tropicalis is an animal model widely used in
studies for both vertebrate development and diseases
because of various advantages including its vigorous
fecundity, fast embryonic development, short generation
period, similar morphogenetic movement as higher
vertebrates and feasibility for forward genetics [1,2].
However, the barriers that impeded this model for
broader use were lack of embryonic stem cell lines and
the methodology of homologous recombination. There-
fore it is difficult to perform specific gene targeting in
Xenopus tropicalis with conventional reverse genetic
methods. Such obstacles have been recently overcome
by engineered endonuclease tools, the zinc finger nucle-
ases (ZFNs) [3] and the transcription activator-like
effector nucleases (TALENs) [4,5]. In particular, TALENs
have been proven to be very effective for gene disruption
in Xenopus as well as other animal models [5-15]. In this
article, we will describe how to perform specific gene dis-
ruption with TALENs in Xenopus tropicalis embryos, and
eventually establish knockout Xenopus tropicalis line.* Correspondence: zhaohui@cuhk.edu.hk; chen_yonglong@gibh.ac.cn
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reproduction in any medium, provided the orTranscription activator-like effector nucleases
TALENs are novel engineered nucleases for gene disrup-
tion and have been successfully applied in a variety of
organisms and cell types including plant [14], Drosophila
[10], C. elegans [13], zebrafish [9,11], Xenopus [4,5], rat
[12], livestock [6], human somatic cells [7], and human
pluripotent stem cells [8]. TALENs consist of two dis-
tinct domains, an engineered DNA-binding domain
derived from the transcription activator-like effector
(TALE) that provides the capability and specificity for
binding target DNA sequence [16,17], and a non-specific
restriction endonuclease Fok I domain fused to the
C-terminal of TALE that confers the nuclease activity of
TALENs [18] (Figure 1A).
TALEs are proteins secreted by Xanthomonas plant
bacteria. These proteins bind to promoters of their
target genes in host cells and activate expression of plant
genes in favor bacterial infection [16,17]. A TALE
protein typically consists of a translocation N-terminal
domain, a nuclear localization signal, C-terminal do-
main, and a central repeat domain. The central repeat
domain indeed provides DNA binding specificity of a
TALE protein. Each repeat unit consists of 34 amino
acids, and their sequences are almost identical except for
two amino acids at the 12th and 13th positions. These
two amino acids which determine the binding specificity
of TALE proteins to DNA bases are called ‘repeat-This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Schematic diagrams of TALEN structure and PCR-
based assay for detection of mutagenesis. (A) Schematic drawing
of TALEN structure. TALEN architecture was optimized for both
zebrafish and Xenopus. Each TALEN monomer consists of a nuclear
location signal (NLS), 152 amino acids deletion N-terminal, 63 amino
acids from C-terminal, the TALE repeat domains, and modified Fok I
nuclease domain ELD/KKR. Each TALE repeat unit consists of 34
amino acids, in which the amino acids at positions 12 and 13 are
called ‘repeat-variable di-residues’ (RVDs). The RVD determine
binding specificity to DNA bases following the code that NG, NI, HD,
and NN respectively recognized thymine, adenine, cytosine and
guanine. (B) Schematic diagram illustrating binding of TALENs to
their targeted DNA sites. Each monomer of a TALEN pair recognizes
and binds DNA via upstream or downstream EBE individually. Two
Fok I nuclease domains ELD and KKR dimerize and function as
endonuclease, generating DNA double strands break (DSB) at spacer
between the two EBE sites. (C) PCR assay determining indel
mutations induced by TALENs. The DNA fragment coving two EBE
sites were amplified with Primer 1/3, the amplicons were then
subcloned into pMD18-T using TA cloning. Primer 1/3 were
employed to check insertion of targeted sequence after TA cloning.
Primer 2 covered the joint region between upstream EBE and the
spacer. When indel mutations were amplified in the spacer region,
no amplicons would be generated by Primer 2/3. The corresponding
plasmids were then sequenced to verify TALEN-induced mutations.
Primer 1/4 may also be introduced to this PCR assay for detection of
some mutations close to the downstream EBE site, which could not
be captured by Primer 2/3. Not drawn to scale.
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known to preferentially recognize adenine (A), thymine
(T), cytosine (C), and guanine (G)/adenine (A), respect-
ively (Figure 1A). Following this code, a given DNA se-
quence can theoretically be recognized by an assembled
array of central repeats of TALE proteins.
Effective endonuclease activity of TALEN requires
dimerization of two monomers that recognize individual
DNA target sites. The Fok I domains on the two mono-
mers designed to bind to adjacent DNA target sites willform a dimer, in turn become activated, generating DNA
double-strand break (DSB) at the spacer region between
two EBEs (Figure 1B). So far, no clear evidence indicates
that TALEN binding to its target sequence is context
dependent, but natural TALE binding site always begins
with a thymine. Moreover, the off-target effects of
TALENs have not been well studied yet, and should be
addressed in detail by research community in the future.
TALEN EBE selection and Golden Gate assembly
As mentioned above, TALENs are effective tools for gene
disruption; the key point for the application of TALENs is
fast and efficient assembly. Currently, there are various
methods for TALEN assembly, such as Golden Gate assem-
bly [7], PCR-based modular assembly [19], FLASH assem-
bly [20], as well as some commercially available approaches
including GeneArt® Precision TALs (Life Technologies) and
TALEN™ (Cellectis bioresearch). Among them, Golden
Gate assembly has been proven to be easy, fast and effect-
ive, therefore suitable for common laboratories. We chose
Golden Gate strategy for TALEN assembly in our studies.
The principle of Golden Gate assembly is based on type IIS
restriction enzymes that can cleave DNA out of their bind-
ing site [21]. In addition to the original report [7], we made
two constructs, pCS2-TALEN-ELD/KKR, which are feas-
ible for microinjection in both zebrafish and Xenopus em-
bryos. We shortened both N- and C-terminal of TALE
backbone, and replaced wild type Fok I with ELD/KKR.
ELD and KKR are both derived from the wild type Fok I
and can form a heterodimer to reduce potential off-target
effects [22]. Our modified Golden Gate TALEN system has
been proven to be suitable and effective in Xenopus
embryos [5].
Previous reports indicated natural TALE binding site
always begins with a thymine and its central repeat do-
main ends with a half repeat unit (0.5 repeat) [16,17]. In
line with this view, the crystal structure of TALE also
suggests that thymine is necessary for its recognition
and binding to DNA, although few reports showed
TALE could still bind to its target sequence without the
thymine [23]. The TALE architecture we chose is
Δ152N-RVDs- + 63C. It has been successfully used for
gene disruptions [24-26], and for genome editing in
zebrafish embryos more recently [27]. The length of EBE
and the spacer were set differently in various studies
[7,24,26,28]. We routinely assemble TALENs harboring
15-20 repeats as such setting showed good DNA binding
specificity and DNA disruption efficiency in Xenopus
embryos [5]. The spacer between two EBE sites is 14-17
bps in our TALEN system.
In this TALEN mutagenesis protocol, we always select
TALEN EBEs that follow a thymine. The RVDs of HD,
NI, and NG preferentially bind to specific nucleotide C,
A and T respectively, but NN is able to recognize both
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reported to have higher binding specificity to G, how-
ever, TALE reporters harboring either NK or NH showed
less activity than NN [29,30]. Therefore currently NN is
still the most commonly used RVD for recognizing G. In
our studies, we tried to avoid G on the target DNA
sequence in order to reduce potential off-target effects
caused by the ambiguity of NN. There are also two web-
based programs public available (http://taleffectors.com/
tools, and https://tale-nt.cac.cornell.edu/node/add/talen)
for TALEN EBE selection.
DNA Repair after double strand break induced
by TALENs
After TALE target selection, we assemble TALE repeats
into pCS2-TALEN-ELD/KKR vectors. TALENs with wide
type Fok I can form homodimers that may cause off-target
effects. ELD/KKR are modified Fok I nuclease domains
each of which carries three point mutations. TALENs
harboring ELD and KKR were proven to have less off-
target effects and higher efficiency because of the obligatory
heterodimer formation [22]. Upon dimerization of ELD
and KKR, a pair of TALENs that binds to adjacent EBEs at
a locus of interest is expected to cleave DNA double-strand
at the spacer, generating DNA double-strand break. The
DSB will activate DNA repair mechanism of either non-
homologous end joining (NHEJ), or homologous recombin-
ation (HR) if the proper DNA templates exist [18]. The
repair of DSB by NHEJ results in small insertions or
deletions (indels) at the cleaved site, leading to disruption
of gene function. Repair of DSBs by HR allows integration
of exogenous sequences at target site.
Microinjection of TALEN mRNAs into
Xenopus embryos
The protocol for TALEN assembly will be described in
the section of Experimental procedure. After we obtain
TALEN constructs that target a DNA sequence of inter-
est, these two TALEN plasmids will be linearized by
NotI (NEB) and the mRNAs for microinjection will be
transcribed in vitro using the linearized DNA as tem-
plates (Ambion). After purification, quality and integrity
of the synthesized mRNAs will be checked by denature
agarose gel, and concentrations will be determined by
spectrophotometer. We normally take 500 pg mRNA/
embryo as a trial dose for injection. The ovulation of
female frogs, in vitro fertilization, embryo manipulation
and microinjection were described below. Alternatively
one can follow the protocol in the Harland Xenopus
tropicalis website (http://tropicalis.berkeley.edu/home/).
Evaluation of mutagenesis rate induced by TALENs
The somatic mutations in the injected embryos are
examined at 48 hours after injection. Five injectedembryos were randomly pooled and the genomic DNA
was extracted for further PCR assay [5], and usually four
embryo pools were used for this assay. To access the
frequency of NHEJ-induced mutagenesis at the target
sites, two pairs of primers were employed for this assay
(Figure 1C). Primer 1/3 can bridge the entire two EBE
regions, and primer 2/3 can link the spacer region and
the downstream EBE region. PCR is performed with
primers 1/3 using the extracted genomic DNA as tem-
plate. The amplicons will be cloned into vector pMD18-
T (Takara) or other equivalent vectors by TA cloning,
colonies will be examined by colony PCR using primer
pairs 1/3 and 2/3, respectively. In case primer 1/3 gener-
ate PCR fragment, but primer 2/3 fail to do so, it will
suggest that the colony harbors mutation, and such
colonies will be further examined by DNA sequencing.
Mutagenesis rate is defined as the ratio of mutant
colonies to total colonies [5].
The mutation rate ¼ Number of mutational colonies
Number of total positive colonies
It should be pointed out that high-dose of TALEN in-
jection may cause defects during embryonic develop-
ment, revealed by curled body axis or microcephaly. To
assess the possible toxicity of TALENs, we also calculate
the ratio of malformation and dead embryos at 48 hr
after microinjection. Such defective embryos will nor-
mally die around metamorphosis.
Evaluation of germ line transmission
The germ line transmission is essential for establishment
of a gene knockout frog line. In addition to evaluation of
somatic mutations, the rest of injected embryos will be
cultured to adult frog for examining germ line transmis-
sion of mutations. The G0 frogs are mosaic, carrying
various mutations in their somatic cells. However, this
situation normally will not affect the germ line transmis-
sion as individual sperm or oocyte only carries one
mutation. To carry out germ line transmission of muta-
tions, individual G0 frog will mate with wild type frog
after HCG stimulation. The fertilized embryos (F1 gen-
eration) will be collected and cultured to stage 41 (about
48 hr post fertilization). Genomic DNA will be extracted
from individual embryos and analyzed by PCR assay
described above for accessing mutagenesis rate. If a F1
embryo carries mutation, it should be heterozygous, and
theoretically approximate 50% colonies will harbor
mutations. The mutagenesis positive colonies will be se-
quenced directly to confirm sequence alternations. The
ratio for germ line transmission is defined as the number
of mutated F1 embryos to the total examined F1 em-
bryos. Sibling F1 embryos will be raised to sexual matur-
ity. The genotyping for individual F1 frogs will be
Figure 2 Workflow for establishing gene knockout Xenopus lines by TALENs. After selection of TALENs target site and assembly of TALEN
plasmids, mRNAs encoding a pair of TALENs were microinjected into Xenopus embryos at one cell stage. The gene disruption efficiency was
examined by PCR-based assay and afterwards sequencing. Some of the injected embryos were raised till sexual maturity. Individual G0 founder
frog was mated with WT frog for germ line transmission to get F1 frogs. The F1 frogs were genotyped before metamorphosis by cutting tail and
were raised to adulthood for intercross. Theoretically, ~25% offspring from F1 Xenopus will be homozygotes frogs carrying a specific
gene mutation.
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Table 3 Colony PCR mix in Golden Gate cloning round 1
Components PCR Mix (μL)
5 × GoTaq Buffer 5
25 mM MgCl2 2.5
10 mM dNTP Mix (Fermentas) 0.5
Primer Fw (10 mM) 0.5
Primer Re (10 mM) 0.5
Colony suspension 5
GoTaq DNA polymerase (Promega) 0.5
dH2O 10.5
Total 25
Table 1 Ligation mix in Golden Gate cloning round 1
Components pFUS_A Mix (μL) pFUS_B Mix (μL)
Buffer 4 (NEB) 1 1
T4 Ligase (NEB) 0.8 0.8
BsaI (NEB) 0.8 0.8
RVD vectors (150 ng/μL) 0.6 × 10 0.6 × #N-1
pFUS_A/B vectors (150 ng/μL) 1 1
ATP (25 mM) 0.4 0.4
dH2O 0 6-(0.6 × #N-1)
Total 10 10
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omic DNA extracted from its tail before metamorphosis
(Figure 2). We often find that several F1 embryos carry
the same mutation. In that case, these two frogs will be
selected for mating and the fertilized embryos (F2) will
be collected. In theory, 25% offspring are homozygous at
the target loci. The F2 frogs will be raised and genotyped
for population expansion of this knockout frog line.
Experimental procedure
Extraction and normalization of TALEN assembly vectors.
1. Recovery and extraction of TALE vectors. Obtain
the Golden Gate vectors from Addgene (Cat
#1000000016 or #1000000024). Use a sterile pipette
tip or inoculation loop to dip bacteria from the
bacterial stab and streak bacteria onto LB Agar
plates with proper antibiotics (see Reagents). On the
second day, pick a single colony and culture it in LB
Broth with appropriate antibiotics overnight. Extract
vector DNA using a standard miniprep kit
(Favorgen)a, and adjust DNA concentration to 150
ng/μL with TE buffer. Store plasmids DNA at −20°C.
2. EBE sequence selection. We routinely choose
TALEN targeting sequences by the following
criteria: 1) Thymine (T) is at position 0 and the EBE
sequence follows this T; 2) the spacer sequence is
around 14-17 bp; 3) minimize the number of
guanine (G) residues in EBE sequences to reduce
ambiguity of RVD NN; 4) select EBEs in an exon or
a junction region between intron and exon.Table 2 Ligation program in Golden Gate cloning round 1





18 80 5TALENs Assembly with Golden Gate Method.
3. Assemble TALENs with Golden Gate method. The
TALEN assembly in principle follows the method
published elsewhere [7] except that we made two
vectors pCS2-TALEN-ELD/KKR for the last step of
assembly [5]. We also have optimized some reaction
conditions. If the TALE length is 12-21, pick vectors
for RVD 1-10 and pFUS_A, then pick RVD vector
11 up to N-1 and pFUS_B#N-1. If the TALE length
is 22-31, pick vectors for RVD 1-10 and
pFUS_A30A, RVD vector 11-20 and pFUS_A30B,
then pick vectors 21 up to N-1 and pFUS_B#N-1.
The last RVD is half repeat and will be assembled in
the cloning round 2.
4. Set up Golden Gate reaction mix (Cloning Round 1)
listed in Table 1.
5. Perform ligation on a thermal cycler from step 4
using the following program in Table 2.
6. Treat the ligation mix with Plasmid-Safe nuclease.
Add 0.5 μL ATP (25 mM) and 0.5 μL Plasmid-Safe™
ATP-Dependent DNase (Epicentre) to each reaction
mix. Incubate at 37°C for 1 hour. Plasmid-Safe
nuclease can digest all unligated linear DNA
including incomplete ligation products with
uncompleted repeats and remaining linearized RVD
vectors and pFUS vectors.Table 4 Colony PCR program in Golden Gate cloning
round 1

















Table 6 Ligation program in Golden Gate cloning round 2






Figure 3 Agarose gel image showing PCR amplicons from
different steps of Golden Gate assembly. pFUS_A vectors contain
1st-10th RVDs repeats (Lane 1) and pFUS_B5 vectors harbor 11th-
15th RVDs repeats (Lane 2) in Golden Gate assembly round 1. The
smeared ladder bands starting at ~300 bp with increase of
approximate every 100 bp indicated successful RVD assembly and
ligation to pFUS_A/B. Unsuccessful insertion led to incorrect size of
amplicons (Lane 3). Lane 4 and 5 represent colony PCRs for pCS2-
TALEN-ELD/KKR vectors carrying RVDs in Golden Gate assembly
round 2. Correct PCR fragments amplified by primer pair of CTalF/
CTalR are about 200 bp after assembly of the RVDs repeats from
pFUS_A, pFUS_B5, and final half RVD repeat, into the
pCS2-TALEN-ELD/KKR vectors.
Lei et al. Cell & Bioscience 2013, 3:21 Page 6 of 10
http://www.cellandbioscience.com/content/3/1/217. Transform 50 μL competent cells (DH5α,
Invitrogen) with ligation mix. Plate the transformed
competent cells on Spectinomycin + LB Agar plate
at 37°C overnight.
8. After 14-16 hr incubation, pick 7 pFUS_A colonies
and 3 pFUS_B colonies. Resuspend each colony with
40 μL dH2O by vortex as PCR template. Prepare
PCR mix as follows in Table 3. (The ligation
efficiencies of both pFUS vectors are usually quite
high. One can normally obtain positive candidate
from 7 pFUS_A and 3 pFUS_B colonies).
9. Check positive clones by colony PCR with Golden
Gate round 1 primers, pCR8_F & pCR8_R (see
Materials) using the following cycling program in
Table 4.
10. Check the amplicons with 1% agarose gel. If the
ligation is successful, colony PCR will generate
smearing ladder bands and the largest band is about
1.2 kb for pFUS_A vectors within 10 RVDsble 5 Ligation mix in Golden Gate cloning round 2
mponents pCS2-TALEN Mix (μL)
ffer 3 (NEB) 1
US_A-RVDs vectors (150 ng/μL) 0.8
US_B-RVDs vectors (150 ng/μL) 0.8
st Repeats vectors (150 ng/μL) 0.6
mbI (NEB) 0.8









33(Figure 3, Lane 1). The gel result of pFUS_B vector
will also form smearing ladder bands with smaller
size. The expected size was depended on the
number of RVDs into pFUS_B vector (Figure 3,
Lane 2).
11. Amplify the colonies harboring correct inserts in
Spectinomycin + LB Broth by vigorous shaking at
37°C overnight.
12. Spin down the bacterial culture and perform mini
prep to extract plasmid DNA (Favorgen). Adjust
plasmid concentration to 150 ng/μL.
13. Set up Golden Gate reaction mix (Cloning Round
2) listed in Table 5.
14. Incubate the reaction mix at 55°C for 30 min
(BsmbI digestion). Add 0.5 μL ATP (25 mM) and
0.5 μL T4 Ligase (NEB) to each reaction mix.
15. Perform ligation on a thermal cycler from step 14
using following program in Table 6.
16. Transform 50 μL competent cells (DH5α,
Invitrogen) with ligation mix. Plate the transformed
E.coli on Ampicillin + LB Agar plate at 37°C
overnight.
17. After 14–16 hr incubation, pick 3 colonies from the
selective agar plates and assess ligation (Step 13–15)
by colony PCR (Step 8) using Golden Gate round 2
primers, CTalF & CTalR (see Materials), with
following conditions Table in 7.
18. Examine the PCR products with 1% agarose gel.
The expected size of amplicons should be about
200 bp (Figure 3, Lane 4 and 5).
19. Amplify the colonies that give correct bands in
Ampicillin + LB Broth at 37°C overnight.
20. Perform mini prep to extract DNA of pCS2-TALEN
-ELD/KKR plasmids containing full RVDsble 7 Colony PCR program in Golden Gate cloning
und 2







Table 8 PCR mix for amplification of target genomic DNA
Components PCR Mix (μL)
5 × GoTaq Buffer 5
25 mM MgCl2 2.5
10 mM dNTP Mix (Fermentas) 0.5
Primer 1/2 (10 mM) 0.5
Primer 3 (10 mM) 0.5
Genomic DNA 0.5
GoTaq DNA polymerase (Promega) 0.5
dH2O 15
Total 25
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primers, NTalF & CTalR (see Materials) to confirm
successful assembly.
Synthesize TALEN mRNAs in vitro.
21. After sequence confirmation of assembled TALEN
constructs, linearize the pCS2-TALEN-ELD/KKR
constructs containing RVD with NotI (NEB). Purify
the linearized DNA with Gel/PCR purification kit
(Favorgen)b according to the manufacturer’s
instructions.
22. Synthesize mRNAs for microinjection with
mMessage mMachine SP6 kit (Ambion) using the
linearized DNA (step 21) as templates. Purify the
synthesized mRNA with RNeasy MiniElut Cleanup
Kit (QIAgen). Check quality and integrity of the
mRNA with denature agarose gel and measure RNA
concentration with spectrophotometer.
Microinjection of TALEN mRNAs into Xenopus embryos
and evaluation of somatic gene disruption efficiency.
23. Prior to mating, induce ovulation of female frogs
with 20 IU human chorionic gonadotropin (hCG) at
night before in vitro fertilizations. Inject another
dose of 200 IU hCG on the next day. The female
frogs lay eggs from 2 hr to 6 hr after hCG injection.
24. Dissect testes from a male frog, and cut testes of
male frog into very small pieces and transfer them
into 1xMMR (high concentration to keep sperm
activity) on ice. Squeeze the ovulated female frog
and collect eggs onto a petrdish. Pipet sperm mix
onto eggs. Briefly mix them well and wait for 3-5
minutes. Pour 0.1xMMR into the dish to cover eggs
till completion of fertilization.
25. Keep eggs at about 25°C throughout fertilization
periods. Collect embryos and remove jelly coat from
the eggs using 3% cysteine hydrochloride (in water,
pH 7.8-8.0) after step 24.
Or follow the Harland tropicalis website to perform fe-
male ovulation, in vitro fertilization, and manipulation.
(http://tropicalis.berkeley.edu/home/obtaining_embryos/
hcg/hCG.html).
26. Microinjection is performed at about 22°C. After
TALENs injection, culture the injected embryos in
0.1xMBS culture medium at 22°C overnight and
then transfer them to 25°C. When the injected
embryos reached about stage 41 (about 48 hr post
fertilization), randomly collect and pool five TALEN-
injected embryos, and extract genomic DNA with
DNeasy blood & tissue Kit (QIAgen) from embryopools according to the manufacturer’s instructions.
Raise the rest of injected embryos to adult frogs for
future germ line transmission.
27. Set up a PCR reaction to amplify the genomic
region that covers two TALEN EBE sites. A pair of
primers flanking the two EBE sites is employed for
this PCR reaction (Figure 1C). According to our
experience, we recommend the length of amplicons
is less than 1 kb. Prepare PCR mix as following in
Table 8.
28. After PCR reaction, check the size of PCR
products, and recover the DNA with gel extraction
kit (Favorgen). The purified amplicons are then
cloned into pMD-18 T vector by TA cloning
(Takara) using the following set-up in Table 9.
29. Incubate the ligation mix at 16°C for 60 min.
30. Transform 50 μL competent cells (DH5α,
Invitrogen) with 10 μL ligation mix. Plate the
transformed DH5α on Ampicillin + LB agar plate at
37°C overnight.
31. Randomly pick up at least 20 colonies for each
embryo pool. Colony PCR is used to access
mutagenesis rate at the targeted sites, using primer
pair 1/3, and primer pair 2/3, respectively (Figure 4).
If mutations are generated in the spacer region, no
amplicon can be amplified using the primer pair 2/3.
Verify mutation by direct sequencing.
32. Raise the sibling TALENs injected Xenopus embryos
till sexual maturity according to (http://tropicalis.
berkeley.edu/home/husbandry/raisetads.html) or
protocol published elsewhere [31]. It takes about
5 months for the injected embryos to reach sexual
maturity, and longer period is also expected
depending on the feeding conditions. Pigment patch
appearing in frog’s claws suggest maturity of male
froglets.
33. When TALENs targeted frogs are ready for germ
line transmission, mate a male or female G0 frog
with a wild type frog. The details are described as








Table 9 TA cloning mix
Components Ligation Mix (μL)
pMD18-T Vector (Takara) 1
Insert DNA (~0.3 pmol) 4
Solution I 5
Total 10
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obtaining_embryos/natural_mating.html). Briefly
prior to mating, inject both male and female frogs
with 20 IU hCG at the night before natural mating
and keep separately to avoid amplexus and possible
fertilizations. Inject another dose of 200 IU hCG to
boost reaction of both male and female frogs and
place them together without disturbances on the
next day.
34. Usually female frogs lay eggs from 2 hr to 6 hr
after the second hCG injection. Keep frogs at
about 25°C throughout the priming and natural
mating periods [31].
35. Collect embryos and remove jelly coat from the
eggs using 3% cysteine hydrochloride (in water,
pH 7.8-8.0). Culture the embryos in 0.1×MBS at 25°
C until at stage 41. Randomly collect 20 embryos,
extract genomic DNA from single embryo, and leave
the sibling embryos to develop to adult frogs.
36. Use the method described in step 27–31 to
determine whether the F1 embryos carry mutations,
and calculate the rate for germ line transmission.
(number of embryos harboring mutations/total
number of examined embryos). After the sibling
embryos developed till stage 45, cut tail for DNA
extraction to determine the genotype at the targeted
loci. Select the larvae carrying open reading frame
(ORF)-shift mutations and raise them to sexual
maturity for the intercrossc.Figure 4 Colony PCR results for evaluation of gene disruption.
Agarose gel showing an example of colony PCR to detect
mutagenesis in ets1-TALEN injected Xenopus tropicalis embryos. The
bands amplified by Primer 1/3 in upper panel (~200 bp) indicate the
colonies harbor the TALEN targeted sites. PCR assay was also carried
out with Primer 2/3 in lower panel. The colonies that can give upper
bands but fail to give lower bands were the positive colonies
carrying potential mutants. The colonies giving both upper and
lower bands did not carry mutants (arrows indicated). Mutations
were further confirmed by sequencing.37. After population expansion of selected F1 adult
frogs, mate the F1 frogs. About 25% offspring from
intercross of F1 adult frogs are homozygous at the
targeted loci according to Mendel’s law. Expand the
frog population with this genome type, and maintain
this Xenopus mutant line.
Conclusion remarks
In our previous studies, TALENs exhibited remarkable
efficiency of gene disruption as well as broad targeting
spectrum of DNA sequence in genome [5]. Those advan-
tages make TALENs a promising gene disruption approach
for specific gene targeting in various animal models includ-
ing Xenopus. In this article, we described the TALENs
protocol currently used in our laboratory for generating
mutations in Xenopus tropicalis embryos. We listed the
criteria for EBE selection and the protocol for TALENs
assembling. The methods of embryo manipulation and
microinjection are basically the same as those used in other
laboratories. We also described a PCR-based method for
detecting the targeted gene disruption efficiency and proce-
dures for establishing a gene-specific knockout Xenopus
line from TALENs injected embryos. The PCR-based evalu-
ation method is simple and reliable. It may miss some mu-
tations that close to the downstream EBE site. We suggest
to introduce a forth primer (Figure 1C) in order to capture
all the possible mutations. TALENs display high efficiency
for generating somatic mutations in G0 embryos. However
it is worth noting that whether TALEN can be used theTable 11 Vectors in Golden Gate Kit (This kit can be
purchased from Addgene)
Tetracycline
pNI1 pNI2 pNI3 pNI4 pNI5 pNI6 pNI7 pNI8 pNI9 pNI10
pHD1 pHD2 pHD3 pHD4 pHD5 pHD6 pHD7 pHD8 pHD9 pHD10
pNN1 pNN2 pNN3 pNN4 pNN5 pNN6 pNN7 pNN8 pNN9 pNN10
pNG1 pNG2 pNG3 pNG4 pNG5 pNG6 pNG7 pNG8 pNG9 pNG10
Spectinomycin
pLR-NI pLR-HD pLR-NN pLR-NG
pFUS_A pFUS_A30A pFUS_A30B
pFUS_B1 pFUS_B2 pFUS_B3 pFUS_B4 pFUS_B5
pFUS_B6 pFUS_B7 pFUS_B8 pFUS_B9 pFUS_B10
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concluded before conducting comparable studies systemat-
ically. ptf1a/p48 TALEN can induce complete loss of xpdip
expression as did ptf1a/p48 morpholino [5], but it seems
that the efficiency is not as profound as that with ptf1a/p48
morpholino knockdown in Xenopus laevis published previ-
ously [32]. We have observed similar effects with other
genes. One explanation could be that the TALEN-injected
embryos are mosaic and the gene disruption efficiencies
vary in different embryos. And even in one embryo harbor-
ing mutations, the somatic mutations are different [5,33].
Moreover, TALEN cannot block functions from the mater-
nal mRNAs. Such complexity may make it difficult to
interpret phenotype induced by TALENs in G0 embryos.
Therefore, we suggest that morpholinos cannot be replaced
by TALENs currently. Although our protocol is for gene
disruption in Xenopus embryos, it is also feasible for
zebrafish with minor modifications of the setting for micro-
injection. With rapid growth of research on TALENs, accu-
mulating data indicate that TALEN is an easy but robust
tool for reverse genetics study. Engineered TALENs will fa-
cilitate and expand applications in various organisms for fu-
ture research.
Materials
Primer List (Table 10).
Golden Gate vectors (Addgene Cat #1000000016 or
#1000000024) (Table 11).
TALENs backbone vectors (Ampicillin)
pCS2-TALEN-ELD, pCS2-TALEN-KKR.
Reagents
T4 DNA ligase (NEB, Cat. no. M0202M)
NotI (NEB, Cat. no. R0189L)
BsaI (NEB, Cat. no. R0535L)
BsmbI (NEB, Cat. no. R0580L)
Plasmid-Safe™ ATP-Dependent DNase (Epicentre, Cat.
no. E3110K)
GoTaq DNA polymerase (Promega, Cat. no. M8295)
pMD18-T vector (Takara, Cat. no. D101A)
FavorPrep Plasmid DNA Extraction mini Kit (Favorgen,
Cat. no. FAPDE001-1)
DNeasy blood&tissue Kit (QIAgen, Cat. no. 69504)
GEL/PCR Purification Kit (Favorgen, Cat. no.
FAGCK001-1)
mMessage mMachine SP6 Kit (Ambion, Cat. no.
AM1340)
RNeasy MiniElute Cleanup Kit (QIAgen, Cat. no. 74204)
LB Broth medium (Usb, Cat. no. 75852)
LB Agar medium (Invitrogen, Cat. no. 22700–025)
Amplicillin (Sigma, Cat. no. A1593)
Spectinomycin (Sigma, Cat. no. S4014)
Tetracycline (Sigma, Cat. no. 87128)GeneRuler 1 kb DNA Ladder (Fermentas, Cat. no.
SM0311/2/3)
DH5α (Invitrogen, Cat. no. 18263–012)
Endnotes
a Miniprep can be performed by equivalent commer-
cial kit.
b Gel extraction or PCR purification can be performed
by equivalent commercial kit.
c It is critical to perform genome typing at the
TALENs targeting sites for all adult F1 frogs prior to
mating. If we find that a few male and female F1 frogs
carry identical mutation, we will mate them directly. If
only one frog has a particular genome type, we cross this
frog with wild type frog again to expand the population.
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